Product News

Artificial Intelligence Product News

DormoVision X Launches at SLEEP 2025

Revolutionizing sleep health with an all-in-one, AI-driven diagnostics platform. Delivering real-time physiological data monitoring and sleep analysis that matches the accuracy and quality of in-lab studies, with the comfort and convenience of at-home testing. Dormotech, a leader in advancing sleep diagnostics through innovative, clinically validated solutions, is proud to launch […]

EnsoData’s Celeste+ App Adds Three New Physical Channels to HSAT ENSOSLEEP PPG
Home Sleep Testing (HST) Product News

EnsoData’s Celeste+ App Adds Three New Physical Channels to HSAT

EnsoData, an innovator in AI healthtech solutions, is enhancing the FDA-cleared EnsoSleep PPG home sleep apnea testing (HSAT) solution by integrating three new physical channels. These channels provide additional physiological data to support sleep clinicians in diagnosing and treating sleep disorders using FDA-cleared pulse oximeters. EnsoData introduces all three channels […]

PranaQ Receives FDA Clearance for TipTraQ
Home Sleep Testing (HST) Artificial Intelligence Product News

PranaQ Receives FDA Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test

PranaQ has received U.S. Food and Drug Administration (FDA) 510(k) clearance for TipTraQ, a single-point-of-contact home sleep apnea test wearable that provides comprehensive sleep and respiratory insights with minimal sleep disruption. “Receiving FDA clearance for TipTraQ is a significant milestone in our mission to revolutionize sleep diagnostics and monitoring,” said […]

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
Product News

LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints

LivaNova PLC, a market-leading medical technology company, announced that it met the primary endpoints for its OSPREY randomized controlled trial (RCT), Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with its safety endpoints, the RCT achieved statistical significance of its primary endpoint responder rates1,2 between the treatment arm […]